Home › Research › Tau biomarkers
[The role of CSF markers in the early diagnosis of Alzheimer's disease]
Vos SJ, Visser PJ, Verhey FR.. Tijdschrift voor psychiatrie, 2011-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Biomarkers in cerebrospinal fluid (CSF) are being used increasingly to diagnose early Alzheimer's disease (AD). A CSF profile that is suggestive of ad is an abnormal ratio of the proteins Ab1-42 to total tau. Aim To describe the prevalence and prognosis of a CSF profile in patients without dementia but with subjective memory problems and mild cognitive impairments (MCI) at a memory clinic.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Vos, S. J., Visser, P. J., & Verhey, F. R. (2011). [The role of CSF markers in the early diagnosis of Alzheimer's disease]. Tijdschrift voor psychiatrie.
Vancouver
Vos SJ, Visser PJ, Verhey FR. [The role of CSF markers in the early diagnosis of Alzheimer's disease]. Tijdschrift voor psychiatrie. 2011. PMID: 21898322.
BibTeX
@article{vos2011-21898322,
author = {Vos, S. J. and Visser, P. J. and Verhey, F. R.},
title = {{[The role of CSF markers in the early diagnosis of Alzheimer's disease]}},
journal = {Tijdschrift voor psychiatrie},
year = {2011},
pmid = {21898322}
}
Built from the record alzhub holds for this paper, not looked up. This record has no DOI, so the citation leaves it out. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- A CSF profile that is suggestive of ad is an abnormal ratio of the proteins Ab1-42 to total tau.
- Aim To describe the prevalence and prognosis of a CSF profile in patients without dementia but with subjective memory problems and mild cognitive impairments (MCI) at a memory clinic.
- Results A European multi-centre study showed that a CSF AD profile was often present in patients with subjective complaints and patients with MCI .
- The CSF AD profile predicted a decline in cognition and daily functioning over a period of 3 years in patients with MCI.
Why it matters
This report describes how a cerebrospinal fluid profile based on the ratio of Ab1-42 to total tau is used to diagnose early Alzheimer's disease, and notes that this profile was often present in patients with subjective complaints and mild cognitive impairment and predicted decline in cognition and daily function. It concerns diagnosis and prognosis only, with no treatment, cure, or prevention tested.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 28/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record and impact for its field and year, so those were left out: it earned 25 of the 90 points we could judge it on, which is 28 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Tijdschrift voor psychiatrie) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2011 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.1 citations a year over 17 year(s) since 2011 |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Frans R J Verhey: h-index 9 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Maastricht University Medical Centre: institution h-index 671 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | PubMed indexes it as a multicentre study |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 21898322) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 25 / 90 | Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 25 of the 90 points we could judge it on is 28 out of 100. |
| Total | 28 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.